|
시장보고서
상품코드
2038995
액체생검 시장 : 바이오마커 유형별, 검체 유형별, 질환별, 최종사용자별, 지역별Liquid Biopsy Market, By Biomarker Type, By Sample Type, By Disease Indication, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
액체생검 시장은 2026년에 13억 5,400만 달러로 추정되고 있으며, 2033년까지 73억 4,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 27.5%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 13억 5,400만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 27.50% | 2033년 시장 규모 예측 : | 73억 4,000만 달러 |
액체생검은 혈액, 뇌척수액(CSF), 혈장, 소변 등의 생체액을 이용해 암을 검출하는 첨단 비침습적 암 진단 기술입니다. 액체생검에서는 순환핵산, 순환종양세포(CTC), 엑소좀을 암 진단의 바이오마커로 활용합니다. 비침습적 진단 방법에 대한 수요 증가는 예측 기간 중 글로벌 액체생검 시장의 성장을 촉진할 것으로 예상됩니다. 또한 암 유병률의 증가는 예측 기간 중 글로벌 액체생검 시장의 성장을 이끄는 주요 요인으로 작용하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 사업 지역, 유통 전략, 주요 개발 및 전략, 향후 계획 등 다양한 매개 변수를 기반으로 세계의 액체생검 시장의 주요 기업 개요을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 액체생검 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 시장 분석에 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 액체생검 시장 : 바이오마커 유형별, 2021-2033년
제5장 세계의 액체생검 시장 : 검체 유형별, 2021-2033년
제6장 세계의 액체생검 시장 : 질환별, 2021-2033년
제7장 세계의 액체생검 시장 : 최종사용자별, 2021-2033년
제8장 세계의 액체생검 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.06.02Liquid Biopsy Market is estimated to be valued at USD 1,354.0 Mn in 2026 and is expected to reach USD 7,340.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 27.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,354.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 27.50% | 2033 Value Projection: | USD 7,340.0 Mn |
Liquid biopsy is an advanced non-invasive cancer diagnostic technique that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. Liquid biopsy uses circulating nucleic acids, circulating tumor cells (CTC), and exosomes as biomarkers for diagnosis of cancer. Increasing demand for non-invasive diagnostic procedures is expected to boost growth of the global liquid biopsy market over the forecast period. Furthermore, increasing prevalence of cancer is a major factor propelling growth of the global liquid biopsy market over the forecast period.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global Liquid Biopsy based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Biocept, Inc., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global Liquid Biopsy report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
- By Biomarker Type
- CTC (Circulating Tumor Cells)
- ctNA (Circulating Tumor Nucliec Acids)
- Exosomes
- By Device Type
- Blood
- Urine
- Others
- By Disease Indication
- Lung Cancer
- Prostate Cancer
- Gastrointestinal Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Others
- By End User
- Hospitals
- Cancer Institutes
- Academic Institutes
- Diagnostic Centers
- Global Liquid Biopsy Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Biocept, Inc.
- Qiagen N.V.
- Trovagene, Inc.
- Janssen Global Services
- LLC, MDxHealth SA, Natera, Inc.
- F. Hoffmann-La Roche Ltd.
- Silicon Biosystems
- Pathway Genomics Corporation
- Sysmex Corporation
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Biomarker Type
- Market Snippet, By Sample Type
- Market Snippet, By Disease Indication
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Technological Advancement
- Regulatory Scenario
4. Global Liquid Biopsy Market, By Biomarker Type, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- CTC (Circulating Tumor Cells)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- ctNA (Circulating Tumor Nucliec Acids)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Exosomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Liquid Biopsy Market, By Sample Type, 2021 - 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Liquid Biopsy Market, By Disease Indication 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Lung Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Gastrointestinal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Prostate Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Breast Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Colorectal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Leukemia
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Others
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
7. Global Liquid Biopsy Market, By End User 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Cancer Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Academic Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
8. Global Liquid Biopsy Market, By Region, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Company Profiles
- Biocept, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen N.V
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trovagene, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Janssen Global Services, LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MDxHealth SA
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Natera, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Silicon Biosystems
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pathway Genomics Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocept, Inc.
10. Section
- References
- Research Methodology
- About us and Sales Contact
